We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$278M
AUM Growth
+$52.8M
Cap. Flow
+$57.6M
Cap. Flow %
20.7%
Top 10 Hldgs %
61.69%
Holding
40
New
13
Increased
9
Reduced
4
Closed
12

Top Buys

Rank Stock Value
1
APOL
Apollo Education Group Inc Class A
APOL
+$14.7M
2
FTD
FTD Companies, Inc. Common Stock
FTD
+$13.2M
3
SKUL
SKULLCANDY INC
SKUL
+$12.8M
4
SPPI
Spectrum Pharmaceuticals Inc
SPPI
+$11M
5
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$10.6M

Top Sells

Rank Stock Value
1
VNDA icon
Vanda Pharmaceuticals
VNDA
+$12.3M
2
RXDX
Ignyta, Inc.
RXDX
+$11M
3
PBY
PEP BOYS MANNY MOE& JACK
PBY
+$10.5M
4
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
+$8.99M
5
WIFI
Boingo Wireless, Inc.
WIFI
+$8.67M

Sector Composition

Rank Sector Weight
1 Healthcare 45.82%
2 Industrials 12.68%
3 Consumer Discretionary 8.32%
4 Financials 4.06%
5 Technology 2.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSPR icon
26
InspireMD
NSPR
$32M
$1.84M 0.66%
1
– –
VERU icon
27
Veru
VERU
$36.1M
$1.08M 0.39%
60,000
-52,600
-47% -$1.41M
RLOC
28
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$636K 0.23%
+202,000
New +$587K
PPLI
29
People Inc
PPLI
$3.1B
– –
-503,587
Closed -$6.07M
MDGL icon
30
Madrigal Pharmaceuticals
MDGL
$12.6B
– –
-92,571
Closed -$6.29M
NERV icon
31
Minerva Neurosciences
NERV
$188M
– –
-25,329
Closed -$1.01M
LL
32
DELISTED
LL Flooring Holdings, Inc.
LL
– –
-180,000
Closed -$5.54M
VCRA
33
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
– –
-906,000
Closed -$8.99M
WIFI
34
DELISTED
Boingo Wireless, Inc.
WIFI
– –
-1,150,000
Closed -$8.67M
PGNX
35
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-1,148,000
Closed -$6.87M
KZ
36
DELISTED
KongZhong Corporation
KZ
– –
-1,250,000
Closed -$6.91M
IRG
37
DELISTED
Ignite Restaurant Group, Inc.
IRG
– –
-240,000
Closed -$1.16M
PBY
38
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
– –
-1,090,000
Closed -$10.5M
IMUC
39
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
– –
-61,788
Closed -$1.2M
RPTP
40
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
– –
-130,000
Closed -$1.41M
1
2

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Armistice Capital held 40 positions worth $278M, up 23% from $226M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital deployed $57.6M of net new capital in Q2 2015, opening 13 new positions and adding to 9 existing holdings. Its largest new stake was FTD Companies, Inc. Common Stock: 458,000 shares worth $12.9M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 46% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanda Pharmaceuticals, an estimated $12.3M trimmed.

  • Armistice Capital's largest Q2 2015 buy was FTD Companies, Inc. Common Stock: 458,000 shares worth $12.9M.
  • Armistice Capital added most to Apollo Education Group Inc Class A in Q2 2015, an estimated $14.7M increase.
  • Armistice Capital's biggest Q2 2015 reduction was Vanda Pharmaceuticals, cutting an estimated $12.3M.
  • Armistice Capital fully exited PEP BOYS MANNY MOE& JACK in Q2 2015, selling an estimated $10.5M.
  • Armistice Capital's ten largest holdings make up 62% of its $278M portfolio in Q2 2015.
  • Armistice Capital opened 13 new positions and closed 12 in Q2 2015.
  • Armistice Capital's portfolio value rose 23% quarter-over-quarter to $278M.

Based on Armistice Capital's 13F filing for Q2 2015, filed 14 Aug 2015.